Cite
HARVARD Citation
Rupoli, S. et al. (2022). Prognosis in early stage cutaneous T‐cell lymphoma treated with psoralen plus ultraviolet A irradiation and low‐dose interferon‐α: Long‐term efficacy and survival according to conventional and emerging clinical endpoints. Dermatologic therapy. 35 (10), p. n/a. [Online].